Myriad Genetics(CH:MYD)
CH:MYD
Myriad Genetics Revenue
Myriad Genetics (MYD) Revenue
0 Followers
Myriad Genetics Revenue
Myriad Genetics had a revenue of 202.70M in the quarter ending Sep 30, 2026, with 6.29%. This bring the company's revenue in the last twelve months to 803.60M, Decreased 0.37%. In the fiscal year ending Dec 31, 2025, Myriad Genetics had annual revenue of 824.50M with -1.56% growth.
- Revenue (ttm)
- 803.60M
- Revenue Growth
- ―
- P/S Ratio
- 0.55
- Revenue/Employee
- CHF 305,370
- Employees
- 2,700
- Market Cap
- CHF 452.64M
Revenue Chart
Myriad Genetics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 824.50M | -13.10M | -1.56% |
| Dec 31, 2024 | 837.60M | 84.40M | 11.21% |
| Dec 31, 2023 | 753.20M | 74.80M | 11.03% |
| Dec 31, 2022 | 678.40M | -12.20M | -1.77% |
| Dec 31, 2021 | 690.60M | 133.60M | 23.99% |
| Jun 30, 2020 | 557.00M | -81.60M | -12.78% |
| Jun 30, 2019 | 638.60M | -212.50M | -24.97% |
| Jun 30, 2018 | 851.10M | 107.40M | 14.44% |
| Jun 30, 2018 | 743.70M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.